A
$ Value
$860K
Shares
11,976
Price
$72
Filed
Apr 2
Insider
Name
Clark James David
Title
SVP, Cont & Chief Acct Officer
CIK
0001757584
Roles
Officer
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
11,976
Footnotes
Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. | Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. | Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
Filing Info
Clark James David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | CVS | F | $236K |
| 2026-03-31 | CVS | A | $800K |
| 2026-03-31 | CVS | A | $860K |
| 2025-12-01 | CVS | F | $17K |
Other Insiders at CVS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Nelson Steven H
EVP and President, Aetna
|
— | — | 2026-04-01 |
|
Joyner J. David
President, CEO and Chair
|
— | — | 2026-04-01 |
|
Khichi Samrat S.
EVP, CPO and General Counsel
|
— | — | 2026-04-01 |
|
CAPOZZI HEIDI B
EVP and Chief People Officer
|
— | — | 2026-04-01 |
|
Compton-Phillips Amy
EVP, Chief Medical Officer
|
— | — | 2026-03-31 |
|
Clark James David
SVP, Cont & Chief Acct Officer
|
— | — | 2026-04-01 |
|
Newman Brian
EVP, Chief Financial Officer
|
— | — | 2026-03-31 |
|
Mandadi Tilak
EVP, Chief Exp & Tech Officer
|
— | — | 2026-04-01 |
|
Shah Prem S
EVP and Group President
|
— | — | 2026-04-01 |